A prospective study of the responsiveness of depression and suicidal ideation in acne patients to different phases of isotretinoin therapy

European Journal of Dermatology

Volumn 15, Issue 6, 2005, Pages 484-488

  Kellett, S C ^a   Gawkrodger, D J ^b  

^a Keresforth Centre   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Acne; Depression; Isotretinoin; Suicidal ideation

Indexed keywords

ISOTRETINOIN;

ACNE; ADULT; AFFECT; ARTICLE; CLINICAL ARTICLE; COGNITION; DEPRESSION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; SELF EVALUATION; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TREATMENT OUTCOME; VALIDATION PROCESS;

ACNE VULGARIS; ADULT; DEPRESSION; DERMATOLOGIC AGENTS; FEMALE; HUMANS; ISOTRETINOIN; MALE; PROSPECTIVE STUDIES; SUICIDE;

EID: 28244457823     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hong C, Schweitzer I. The association between depression and isotretinoin usage in acne. Austr New Zeal J Psych 2003; 37: 78-84.
2. Pawin H, Beylot C, Chivot M, Fuare M, Poli F, Reuuz J, et al. Physiopathology of acne vulgaris: recent data, new understanding of treatments. Eur J Dermatol 2004; 14: 4-12.
3. King K, Jones DH, Daltrey DC, et al. A double-blind study of the effect of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol 1982; 107: 583-90.
4. Daiziel K, Barton S, Marks R. The effects of isotretinoin on fibilicular and sebaceous gland differentiation. Br J Dermatol 1987; 117: 317-23.
5. Leyden JJ, McGinfey KJ. Effect of 13-cis-retinoic acid on sebum production and propionibacterium acnes in severe nodulocystic acne. Arch Dermatol Res 1982; 272: 331-7.
6. Falton RH, Lee WL, Shalita AR, et al. In vivo effect of isotretinoin on monocyte chemotaxis. J Invest Dermatol 1986; 86: 550-2.
7. Cunliffe WJ, Baxter K. The place of oral isotretinoin in the treatment of acne: Benefits and side effects. CME Bulletin Dermatol 2000; 2: 56-62.
8. Farrell LN, Strauss JS, Stranieri AM. The treatment of severe cystic acne with 13-cis-retinoic acid: Evaluation of sebum production and the clinical response in a multiple - dose trial. J Am Acad Dermatol 1980; 3: 602-11.
9. Dreno B, Daniel F, Allaert FA, Aube I. Acne; evolution of the clinical practice and therapeutic management of acne between 1996 and 2000. Eur J Dermatol 2003; 13: 166-70.
10. Hull PR, Demkiw-Bartel C. Isotretinoin use in acne: Prospective evaluation of adverse effects. J Cuta Med Surg 2000; 4: 66-70.
11. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms suicide and attempted suicide. Arch Dermatol 2000; 136: 1231-6.
12. Krezel W, Ghyselinck N, Samad TA, et al. Impaired locomotion and dopamine signalling in retinoid receptor mutant mice. Science 1998; 279: 863-7.
13. Byne A, Hnatko G. Depression associated with isotretinoin therapy. Canadian J Psych 1995; 40: 567.
14. Duke E, Guenther L. Psychiatric reactions to the retinoids. Can J Dermatol 1993; 5: 467.
15. Bravard P, Krug M, Rzeznick JC. Isotretinoin et depression, soyons vigilantes. Nouv Dermatol 1993; 12: 15.
16. Gatti S, Serri F. Acute depression from isotretinoin. J Am Acad Dermatol 1991; 25: 132.
17. Ng CH, Tam MM, Hook SJ. Acne, isotretinoin treatment and acute depression. W J Biol Psych 2001; 2: 159-61.
18. Ault A. Isotretinoin use may be linked with depression. Lancet 1998; 351: 730.
19. Hazen PG, Carney JF, Walker AE, Stewart JJ. Depression - a side effect of 13-cis-retinoic acid. J Am Acad Dermatol 1983; 9: 278-9.
20. Scheinman PL, Peck GL, Rubinow DR, DiGiovanna JJ, Abangan DL, Ravin PD. Acute depression and isotretinoin. J Am Acad Dermatol 1990; 22: 1112-4.
21. Wysowski DK, Pitts M, Beitz J. Depression and suicide in patients treated with isotretinoin. N Engl J Med 2001; 344: 460.
22. Goulden V, Layton AM, Cunliffe WJ. Long-term safety of isotretinoin in the treatment of acne vulgaris. Br J Dermatol 1994; 131: 360-3.
23. Ng CH, Tam MM, Celi E, Tate B, Schweitzer I. A prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Aust J Dermatol 2002; 43: 262-8.
24. Kellett SC. Shame-fused acne: A biopsychosocial conceptualisation and treatment rationale. In: Gilbert P, Miles J, eds. Body Shame: Conceptualisation, Research and Treatment. Hove: Brunner-Routledge, 2002.
25. Beck AT, Steer RA, Brown GK. BDI-II manual. The Psychological Corporation. San Antonio: Harcourt Brace & Company, 2000.
26. Beck AT, Kovacs M, Weissman A. Hopelessness and suicidal behaviour: An overview. JAMA 1975; 234: 1146-9.
27. Beck AT, Brown G, Berchick RJ, Stewart BL, Steer RA. Relationship between hopelessness and ultimate suicide: A replication with psychiatric out-patients. Am J Psych 1990; 147: 190-5.
28. Zich JM, Attkisson CC, Greenfield TK. Screening for depression in Primary Care: The CES-D and the BDI. Intern J Psych Med 1990; 20: 259-77.
29. Allen BS, Smith JG. Various parameters for grading acne vulgaris. Arch Dermatol 1982; 118: 23-7.
30. Kellett SC, Gawrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140: 273-82.
31. Cotterill JA, Cunliffe WJ. Suicide in dermatology patients. Br J Dermatol 1988; 137: 246-50.
32. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846-50.
33. Rubinow DR, Peck GL, Squillance KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with isotretinoin. J Am Acad Dermatol 1987; 17: 25-32.
34. MacDonald Hull S, Cunliffe WJ, Hughes BR. Treatment of the depressed and dysmorphic acne patient. Clin Exp Dermatol 1991; 16: 210-1.